NEU 3.26% $21.09 neuren pharmaceuticals limited

Ok Friends, the concept succinctly for easy translation :...

  1. 517 Posts.
    lightbulb Created with Sketch. 1221
    Ok Friends,

    the concept succinctly for easy translation :
    Treaugus enters QRX called by the largest shareholder of QRX and NEU (Walker Group).Walker has imposed Treaugus to the rest of the shareholders. Mr. Holaday who worked in Neuren remains in QRX as the father of the study of Dystonia done by QRX in 2008 with fund US ARMY.

    Treagus 4 August became director in BTC with the aim of raising capital for biotech valid in Australia.
    Glass because it allows them to perform these charges Treagus ??
    Neuren to date has been funded by US ARMY and shareholders (Walker and us ....).

    Neuren needs a big biotech that puts money in parallel to US ARMY. with the potential current can not make the leap.
    US ARMY has the need to lock up their studies with Neuren and requires Neuren who and how to enter.
    Treagus Walker and with approval of Glass are creating a structure around Neuren reserved and complicit in US ARMY. not random aversion entrance of American capital typically speculative and unreliable as demonstrated in the past (spring tree).

    next appointment for the market in late October news from Budapest.

    hello
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.09
Change
-0.710(3.26%)
Mkt cap ! $2.693B
Open High Low Value Volume
$21.74 $21.78 $21.03 $7.303M 342.4K

Buyers (Bids)

No. Vol. Price($)
1 377 $21.08
 

Sellers (Offers)

Price($) Vol. No.
$21.10 257 1
View Market Depth
Last trade - 16.10pm 17/05/2024 (20 minute delay) ?
Last
$21.16
  Change
-0.710 ( 3.28 %)
Open High Low Volume
$21.72 $21.72 $21.03 92331
Last updated 15.59pm 17/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.